We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
APN.JSE

Price
16485.00
Stock movement down
-143.00 (-0.86%)
Company name
Aspen Pharmacare Holdings Ltd
Exchange
(JSE
,
Currency
ZAC
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
7323.18B
Ent value
7365.14B
Price/Sales
95.31
Price/Book
86.30
Div yield
-
Div growth
-
Growth years
-
FCF payout
57.60%
Trailing P/E
902.43
Forward P/E
856.36
PEG
-
EPS growth
17.77%
1 year return
-18.12%
3 year return
-9.87%
5 year return
8.18%
10 year return
-8.44%
Last updated: 2025-01-02

DIVIDENDS

APN.JSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E902.43
Price to OCF649.97
Price to FCF1840.92
Price to EBITDA366.31
EV to EBITDA368.40

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales95.31
Price to Book86.30
EV to Sales95.86

FINANCIALS

Per share

Loading...
Per share data
Current share count444.23M
EPS (TTM)18.27
FCF per share (TTM)8.96

Income statement

Loading...
Income statement data
Revenue (TTM)76.84B
Gross profit (TTM)34.04B
Operating income (TTM)13.91B
Net income (TTM)8.12B
EPS (TTM)18.27
EPS (1y forward)19.25

Margins

Loading...
Margins data
Gross margin (TTM)44.30%
Operating margin (TTM)18.10%
Profit margin (TTM)10.56%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash12.34B
Net receivables10.30B
Total current assets44.09B
Goodwill5.46B
Intangible assets66.35B
Property, plant and equipment0.00
Total assets139.16B
Accounts payable4.37B
Short/Current long term debt36.46B
Total current liabilities24.38B
Total liabilities54.29B
Shareholder's equity84.86B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)11.27B
Capital expenditures (TTM)5.92B
Free cash flow (TTM)3.98B
Dividends paid (TTM)2.29B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity9.56%
Return on Assets5.83%
Return on Invested Capital8.44%
Cash Return on Invested Capital4.14%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open16600.00
Daily high16774.00
Daily low16324.00
Daily Volume685K
All-time high44300.00
1y analyst estimate22150.00
Beta0.58
EPS (TTM)18.27
Dividend per share-
Ex-div date18 Sep 2024
Next earnings date3 Mar 2025

Downside potential

Loading...
Downside potential data
APN.JSES&P500
Current price drop from All-time high-62.79%-3.58%
Highest price drop-85.33%-56.47%
Date of highest drop20 Aug 20199 Mar 2009
Avg drop from high-30.58%-11.12%
Avg time to new high20 days12 days
Max time to new high2475 days1805 days
COMPANY DETAILS
APN.JSE (Aspen Pharmacare Holdings Ltd) company logo
Marketcap
7323.18B
Marketcap category
Large-cap
Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Employees
8867
Investor relations
-
CEO
Country
South Africa
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found